Mike Miller, PD in Lepanto, AR - Pharmacist

Mike Miller, PD is a Pharmacist based in Lepanto, Arkansas. Mike Miller is licensed to practice in Arkansas (license number AR07613) and his current practice location is 102 W Broad St, Lepanto, Arkansas. He can be reached at his office (for appointments etc.) via phone at (870) 475-2977.

NPI number for Mike Miller is 1538444252 and his current mailing address is 102 W Broad St, Lepanto, Arkansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1538444252.

Contact Information

	Mike Miller, PD
	102 W Broad St, Lepanto, AR 72354-2200
	(870) 475-2977
	Not Available

Healthcare Provider's Profile

Full Name	Mike Miller
Gender	Male
Speciality	Pharmacist
Location	102 W Broad St, Lepanto, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1538444252
Provider Enumeration Date: 10/13/2011
Last Update Date: 02/15/2017

Medical Identifiers

Medical identifiers for Mike Miller such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538444252	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	AR07613 (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mike Miller is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mike Miller, PD 102 W Broad St, Lepanto, AR 72354-2200 Ph: (870) 475-2977	Mike Miller, PD 102 W Broad St, Lepanto, AR 72354-2200 Ph: (870) 475-2977

News Archive

New, previously unrecognized source of heart stem cells discovered

Researchers at Children's Hospital Boston are continuing to document the heart's earliest origins. Now, they have pinpointed a new, previously unrecognized group of stem cells that give rise to cardiomyocytes, or heart muscle cells. These stem cells, located in the surface of the heart, or epicardium, advance the hope of being able to regenerate injured heart tissue.

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Norman H. Lee, Ph.D., professor of pharmacology at the George Washington University School of Medicine and Health Sciences (SMHS), received a total of $405,001 in grant funding from the National Institute on Drug Abuse (NIDA) to continue to study the correlation between genetics and susceptibility to drug abuse.

Study clarifies risk of recurrence for high-risk breast cancer patients

High-risk breast cancer patients do not appear to have a higher risk of relapse than the general breast cancer population during the first two years after diagnosis, unless their cancer has spread to more than 10 axillary lymph nodes, Italian researchers reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

Executive wellness a legit corporate expense

At least once a year, executives from Ciena Corp. spend a day at Johns Hopkins University getting poked and prodded as they undergo tests for a barrage of potential ailments, from anemia to prostate cancer. They

Research offers hope for treatment of age-related blindness

Rheumatoid arthritis patients treated with anti-inflammatory drugs are 10 times less likely to develop age-related macular degeneration (AMD), the most common form of blindness in people over 55, researchers at the University of British Columbia and University of Saskatchewan have found.

Mike Miller, PD - Pharmacist in Lepanto, AR